TABLE 2.
Live Birth Prevalence of CHDs and CCHDs in Metropolitan Atlanta, Georgia: 1979–2005
Period | Births | Cases per 10 000 Live Births (95% CI) |
||
---|---|---|---|---|
All CHDs | All CCHDs | CCHD Primary Targets | ||
1979–1986 | 228 566 | 50.1 (47.3–53.1) | 17.1 (15.5–18.9) | 11.9 (10.5–13.4) |
1987–1993 | 264 060 | 55.0 (52.3–57.9) | 16.4 (14.9–18.0) | 11.3 (10.1–12.6) |
1994–1999 | 255 847 | 68.9 (65.8–72.2) | 17.9 (16.4–19.7) | 11.3 (10.1–12.7) |
2000–2005 | 308 068 | 84.5 (81.3–87.8) | 17.8 (16.4–19.3) | 11.2 (10.1–12.5) |
Total | 1 056 541 | 65.9 (64.4–67.5) | 17.3 (16.5–18.1) | 11.4 (10.8–12.1) |
CCHDs include primary targets (hypoplastic left heart syndrome, transposition of the great arteries, tricuspid atresia, truncus arteriosus, tetralogy of Fallot, total anomalous pulmonary venous return, and pulmonary atresia) and secondary targets (interrupted aortic arch, coarctation of the aorta, double outlet right ventricle, Ebstein’s anomaly, and single ventricle) of screening.